It can promote tumor progression and treatment resistance by modulating CAF activity, cancer cell signaling, and protein homeostasis, while also acting as a tumor suppressor by inhibiting PNO1 and activating the p53/p21 pathway under specific conditions. The gene discussed is TP53; the disease is neoplasm.